Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Cancer Discovery|April 6, 2021
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell TherapyGregory M Chen, Changya Chen, Rajat K Das, et al.Cancer Research|September 13, 2015
CD73 is associated with poor prognosis in high-grade serous ovarian cancerMartin Turcotte, Kathleen Spring, Sandra Pommey, et al.Plos Computational Biology|June 29, 2016
A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML PrognosisDavid P Noren, Byron L Long, Raquel Norel, et al.Nature Biomedical Engineering|October 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapyÁngel Ramírez-Fernández, Alexander J Dimitri, Fang Chen, et al.Blood Advances|February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemiaJason Xu, Michael McCoy, Zachary Martinez, et al.The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.Nature|April 10, 2024
FOXO1 is a master regulator of memory programming in CAR T cellsAlexander E Doan, Katherine P Mueller, Andy Y Chen, et al.Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.Blood|March 18, 2025
STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALLJason Xu, Jonathan H Sussman, Austin Yang, et al.Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.Pageof 3